1. Canada Stocks

  2. •

    Producer manufacturing

  3. •

    Trucks/Construction/Farm machinery
FluroTech Ltd.

FluroTech Ltd.

TTSXV:TEST.H
0.01
CAD
0.00
(0.00%)
-0.01EPS
232,055.17Market Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic EPS, GAAP
-0.2
-0.11
-0.12
-0.09
-0.1
-2.39
-1.44
-0.74
-1.56
-0.14
-0.01
-0.06
-0.01
-0.01
Free Cash Flow per Basic Share
-0.27
-0.09
-0.11
-0.08
-0.1
-2.25
-1.23
-0.55
-0.41
-0.02
-0.02
-0.05
-0.01
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
0.71
0.6
0.47
0.39
0.29
1.68
0.84
0.13
0.1
-0.01
-0.02
-0.01
-0.01
-0.02
Tangible Book Value per Share
0.71
0.6
0.47
0.39
0.29
1.68
0.84
0.13
0.1
-0.01
-0.02
-0.01
-0.01
-0.02
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
2
3
4
7
8
8
18
23
23
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
- -
- -
- -
- -
-5
-4
-3
-11
-1
- -
-1
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Working Capital
- -
- -
- -
- -
- -
5
3
- -
- -
- -
- -
- -
- -
- -
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
- -
- -
- -
- -
- -
6
3
- -
1
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
-26.77
-17.09
-23.16
-19.84
-29.2
-176.06
-99.51
-152.38
-1,705.27
- -
- -
- -
- -
- -

Capital Structure

CAD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
23
23
23
Market Capitalization
- -
- -
- -

Working Capital

CAD

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

CAD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
427.82%
27.58%
83.75%
Free Cash Flow
1,086.36%
71.25%
-85.74%
Net Income, GAAP
1,248.47%
205.95%
-87.33%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

CAD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

CAD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.03
-0.02
-0.02
- -
-0.06
2025
- -
- -
- -
- -
-0.01
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

CAD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Richard Joel Paolone
Sector
Producer manufacturing
Industry
Trucks/Construction/Farm machinery
Address
Calgary Canada
IPO Date
Mar 22, 2011
Website
flurotech.com
Similar Companies
Caterpillar, Inc. (NYSE:CAT)
Deere & Company (NYSE:DE)
Ashok Leyland Limited (NSE:ASHOKLEY)
Mazagon Dock Shipbuilders Ltd. (NSE:MAZDOCK)
Cochin Shipyard Limited (NSE:COCHINSHIP)
Action Construction Equipment Limited (NSE:ACE)
Business
FluroTech Ltd. is a Canada-based technology company that specializes in the development and commercialization of spectroscopy-based analytical testing platforms and laboratory instrumentation. The company's core technological offering centers on its proprietary CompleTest system, an automated and portable analytical device utilizing two-dimensional fluorescence spectroscopy designed for rapid, cost-effective, on-site biochemical and chemical analysis. Its main products and services include the CompleTest benchtop spectroscopy analyzer; specialized single-use consumable test cartridges and reagent kits; quantitative testing assays for cannabinoid profiling, including tetrahydrocannabinol (THC), cannabidiol (CBD), cannabinol (CBN), and cannabigerol (CBG); screening protocols for environmental and chemical contaminants, such as heavy metals, pesticides, and mycotoxins; pathogen and microbial detection solutions; proprietary analytical software for automated test calibration and data interpretation; and cloud-based data analytics and regulatory compliance reporting platforms. The company primarily targets licensed cultivators, extractors, commercial testing laboratories, agricultural enterprises, and research institutions across North America, with a focus on Canada and the United States. FluroTech Ltd. was founded in 2018 and is headquartered in Calgary, Alberta, Canada. In recent operational and corporate developments, the company transitioned its listing from Tier 2 of the TSX Venture Exchange to the NEX board under the symbol TEST.H due to a realignment of its operating scale. FluroTech has undertaken corporate restructuring initiatives and actively focuses on evaluating strategic alternatives, including potential reverse takeovers, corporate mergers, intellectual property licensing agreements, and asset acquisition opportunities aimed at reactivating commercial operations and restoring an active public market listing.